Posts

Bethesda, Maryland – The Bladder Cancer Advocacy Network (BCAN) would like to thank Senators Bob Menendez (D-NJ) and Johnny Isakson (R-GA), as well as every… Read more

Presented by Matthew Mossanen, MD, from the Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Guru Sonpavde, MD, from Dana-Farber Cancer Institute and from Mayo Clinic and Kent Mouw, MD, PhD, from the Brigham… Read more

Presented by Seth Lerner, MD, from the Baylor College of Medicine, and Gopa Iyer, MD, from Memorial Sloan Kettering Cancer Center. Year: 2018 Part I: What is Targeted Therapy? Video | … Read more

Presented by Robert Svatek, MD, from the UT Health Science Center, San Antonio, Parminder Singh, MD, from Mayo Clinic and Rick Bangs, patient advocate. Year: 2018 Part I: The… Read more

How does immunotherapy work?  Peter H. O’Donnell, MD, from The University of Chicago, Section of Hematology/Oncology, explains immunotherapy as a bladder cancer treatment and addresses… Read more

Leading bladder cancer experts have provided a more in-depth look at topics in which patients have expressed a greater interest.  Additional topics will be coming… Read more

February 16, 2018– Today Photocure ASA announced the FDA approval of new indications for Blue Light Cystoscopy (BLC™) with Cysview®.  This supplemental new drug application… Read more

Amsterdam, NL and Bethesda, US – IOS Press, an international scientific, technical and medical publisher, and the Bladder Cancer Advocacy Network (BCAN), are pleased to… Read more

KNOW THE FACTS Bladder cancer is the 6th most commonly diagnosed cancer in the United States – 4th among men and 11th among women.  Bladder cancer… Read more